Bill Nye, the-Sci-ence Guy
Biill Nyye, the Science Guuy
Bill! Bill! Bill! Bill! Bill! Bill!
Bill Nye, the-Sci-ence Guy
(Science rules)
Bill Nye, the-Sci-ence Guy
(Inertia is a property of matter)
Bill, Bill, Bill, Bill-Bill-Bill-
Biill Nyye, the Science Guuy
Bill! Bill! Bill! Bill! Bill! Bill! Bill! Bill! Bill! Bill!
(T-minus seven seconds)
Bill Nye, the-Sci-ence Guy
[more inside]
posted by troll on Aug 4, 2011 - 101 comments

Followup to this post: A US District Court has ruled that Myriad Genetic's patents on breast cancer genes BRCA1 and BRCA2, which allow them to hold exclusive rights to a widely used genetic test for inherited breast and ovarian cancer susceptibility, are invalid. Genomics Law Report analyzes the ruling in two posts. The decision is likely to be challenged in a legal appeal — but if upheld, it could have huge implications for the biotechnology industry. [more inside]
posted by zarq on Mar 31, 2010 - 51 comments

On behalf of medical organizations, universities, & individual patients, pathologists and genetics researchers, the ACLU has filed a lawsuit against Utah-based Myriad Genetics and the US Patent and Trademark Office. Myriad holds the US patents to the BRCA1 and BRCA2 genes, associated with hereditary causes of breast and ovarian cancers. Their patents guarantee the company the right to prevent anyone else from testing or studying those genes, which the ACLU says is unconstitutional and inhibits researchers from finding treatments and cures. [more inside]
posted by zarq on May 13, 2009 - 64 comments

The ethical problems of biotech patents have been noted here before. Now the New Scientist reports that those patent applications are on the brink of crippling the world wide patent system to the detriment of real inventions and to the disadvantage of poorer countries (and what is the PC term for those now that 'third world' and even 'less developed countries' have fallen out of favor?)
posted by norm on Dec 12, 2000 - 6 comments